Objective. The clinical course of SSc depends on subtype, organ involvement and age. Few data are reported on patients suffering from late-onset SSc. Methods. We analysed data from 8554 patients prospectively followed in the EULAR Scleroderma Trials and Research (EUSTAR) group database. Late-onset SSc was defined as onset of non-RP disease features at or beyond 75 years of age. Disease characteristics, clinical features, disease course and mortality were evaluated. Results. A total of 123 patients with SSc onset at or beyond 75 years of age were identified. Compared with patients <75 years they had more frequently limited than diffuse SSc and a higher prevalence of anti-centromere autoantibodies. Fewer old patients had digital ulcers. The m...
Objective. The aim of the present study was to explore the long-term outcome and clinical characteri...
OBJECTIVES Mortality and worsening of organ function are desirable endpoints for clinical trials in...
OBJECTIVES To describe differences in clinical presentation between men and women in a large group ...
Peak age at onset of systemic sclerosis (SSc) is between 20 and 50 years, although SSc is also descr...
Objective: The aim of this study was to analyse differences in clinical presentation in patients wit...
Abstract: Peak age at onset of systemic sclerosis (SSc) is between 20 and 50 years, although SSc is ...
Objective. The aim of the present study was to explore the long-term outcome and clinical characteri...
OBJECTIVES: The early trajectory of skin fibrosis provides insights into the disease course of syste...
Objective: Systemic sclerosis (SSc) is a systemic autoimmune disease with high morbidity and signifi...
Background: We have previously compared outcome in two groups of systemic sclerosis (SSc) patients w...
Systemic sclerosis (SSc) is a systemic autoimmune disease charac- terised by generalized microangiop...
ABSTRACT Objective. Systemic sclerosis (SSc) is a severe multiple-organ disease charac- terised by ...
Objectives Mortality and worsening of organ function are desirable endpoints for clinical trials in ...
Objectives Mortality and worsening of organ function are desirable endpoints for clinical trials in ...
Objectives: Systemic sclerosis (SSc) is a rare disease of connective tissue, manifestations of which...
Objective. The aim of the present study was to explore the long-term outcome and clinical characteri...
OBJECTIVES Mortality and worsening of organ function are desirable endpoints for clinical trials in...
OBJECTIVES To describe differences in clinical presentation between men and women in a large group ...
Peak age at onset of systemic sclerosis (SSc) is between 20 and 50 years, although SSc is also descr...
Objective: The aim of this study was to analyse differences in clinical presentation in patients wit...
Abstract: Peak age at onset of systemic sclerosis (SSc) is between 20 and 50 years, although SSc is ...
Objective. The aim of the present study was to explore the long-term outcome and clinical characteri...
OBJECTIVES: The early trajectory of skin fibrosis provides insights into the disease course of syste...
Objective: Systemic sclerosis (SSc) is a systemic autoimmune disease with high morbidity and signifi...
Background: We have previously compared outcome in two groups of systemic sclerosis (SSc) patients w...
Systemic sclerosis (SSc) is a systemic autoimmune disease charac- terised by generalized microangiop...
ABSTRACT Objective. Systemic sclerosis (SSc) is a severe multiple-organ disease charac- terised by ...
Objectives Mortality and worsening of organ function are desirable endpoints for clinical trials in ...
Objectives Mortality and worsening of organ function are desirable endpoints for clinical trials in ...
Objectives: Systemic sclerosis (SSc) is a rare disease of connective tissue, manifestations of which...
Objective. The aim of the present study was to explore the long-term outcome and clinical characteri...
OBJECTIVES Mortality and worsening of organ function are desirable endpoints for clinical trials in...
OBJECTIVES To describe differences in clinical presentation between men and women in a large group ...